Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121541333 | 12154133 | 3 | F | 20160815 | 20160307 | 20160823 | PER | US-AMGEN-USASL2016026486 | AMGEN | 66.00 | YR | E | M | Y | 0.00000 | 20160823 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121541333 | 12154133 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121541333 | 12154133 | 1 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121541333 | 12154133 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121541333 | 12154133 | Abasia | |
121541333 | 12154133 | Arthralgia | |
121541333 | 12154133 | Deafness | |
121541333 | 12154133 | General physical condition abnormal | |
121541333 | 12154133 | Malaise | |
121541333 | 12154133 | Mobility decreased | |
121541333 | 12154133 | Musculoskeletal pain | |
121541333 | 12154133 | Neuropathy peripheral | |
121541333 | 12154133 | Off label use | |
121541333 | 12154133 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121541333 | 12154133 | 1 | 201001 | 0 |